Novelties in the field of macrolides

Bibliography

• CHU DTW: Recent developments in 14- and 15-membered macrolides. Exp. Opin. Invest. Drugs (1995) 4 (2):65–94.
   Google Scholar
• BRYSKIER A, AGOURIDAS C, CHANTOT JF: Ketolides:new semi-synthetic 14-membered-ring macrolides. In: New Macrolides, Azalides and Streptogramins - Expanding Indications for the Clinical Practice. Zinner S, Young LS, Acar JF, Neu HC (Eds.), Marcel Dekker, New York, USA (1997):37–50.
   Google Scholar
• BRYSKIER A, AGOURIDAS C, CHANTOT JF: Classificationsof macrolide antibiotics. In: Macrolides, Chemistry, Phar-macology and Clinical Uses. Btyskier AJ, Butzler JP, Neu HC, Tulkens PM (Eds.), Arnette Blackwell, Paris (1993)5–66.
   Google Scholar
• KUJUNDZIC N, PAVLOVIC D, KROHEBEL G et al.: Struc-ture activity relationships of 14- and 16-membered urea-type macrolides. 3rd International Conference on Macrolides, Azalides and Streptogramins. Lisbon, Portugal (1996).
   Google Scholar
• GRANDJEAN C, LUKACS G: Preparation and in vitro anti-bacterial activity of 9-0-glycosyloxime derivatives of erythromycin A, a new class of macrolide antibiotics. J. Antibiot. (1996) 49:1036–1043.
   PubMed Web of Science ®Google Scholar
• KAWASHIMA Y, YAMADA Y, ASAKA T et al.: Structure-activity relationship study of 6-0-methylerythromycin 9-0-substituted oxime derivatives. Chem. Pharm. (1994) 42:1088–1095.
   Google Scholar
• HANSCH C, FUJITA T: A method for the correlation ofbiological activity and chemical structure. J. Am. Chem. Soc. (1964) 86:1616–1626.
   Web of Science ®Google Scholar
• LABRO MT, ABDELGHAFFAR H, KIRST H: Structure-activity relationships among erythromycylamine (ECM) derivatives for their effects on human neutro-phils (PMN) in vitro. 37th ICAAC. Toronto, Canada (1997): 191. Abstract F–268.
   Google Scholar
• BRYSKIER A, AGOURIDAS C: Azalides: a new medicinalchemical family. Curr. Opin. Invest. Drugs (1993) 2:687–694.
   Google Scholar
• KUJUNDZIC N, KOBREHEL G, BANIC Z, KELNERIC Z, KOICB-PRODIC B: Azalides: synthesis and antibacterial activ-ity of novel 9a-N-(N'-substituted carbamoyl and thiocar-bamoyl) derivatives of 9-deoxo-9a-aza-9a-homo erythromycin A. Eur. J. Med. Chem. (1995) 30:455–462.
   Web of Science ®Google Scholar
• LAZAREVSKI G, KOBREHEL G, KELNERIC Z, METELKO B:Synthesis of novel secomacrolides and secoazalides. 3rd Intern. Conf Macrolides, Azalides, and Streptogramins. Lisbon, Portugal (1996).
   Google Scholar
• GILL CJ, ABRUZZO, GK FLATTERY AM et al.: In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythro-mycin, azithromycin and clarithromycin. J. Antibiot. (1995) 48:1141–1147.
   Google Scholar
• KNUDSEN LF, CURTIS JM: The use of angular transforma-tion in biologic assays. J. Am. Stat. Soc. (1947) 42:282–296.
   PubMed Web of Science ®Google Scholar
• BONNEFOY A, GIRARD AM, AGOURIDAS C, CHANTOT JF: Ketolides lack inductibility properties of MLSB resis-tance phenotype. J. Antimicrob. Chemother. (1997) 40:85–90.
   PubMed Web of Science ®Google Scholar
• RODEN BA, CHEMBURKAR S, FREIBERG L, KU YY, PARIZAR: Synthesis of the macrolide antibiotic, oxolide. Bioorg. Med. Chem. Lett. (1995) 5:1307–1310.
   Web of Science ®Google Scholar
• AGOURIDAS C, BENEDETTI V, DENIS A et al: Ketolides, anew distinct semi-synthetic class of macrolides. 34th ICAAC. Orlando, FL, USA (1990227. Abstract F–164.
   Google Scholar
• LABRO NT, ABDELGHAFFAR H, BRYSKIER A: Characteris-tics of the cellular accumulation of through RU004 by human neutrophils (PMN). Comparison with azithro-mycin (AZO and roxithromycin (ROX). 36th ICAAC (1996):139. Abstract F–224.
   Google Scholar
• RENAUDIN H, AYDIN MD, BEBEAR C: Ketolides and Mycoplavma in vitro evaluation of RU 004. 35th ICAAC. San Francisco (CA) (1995):142. Abstract F–168.
   Google Scholar
• SCHÜLIN T, WENNERSTEN CB, MOELLERING RC, Jr., ELIO-POULOS GM: In vitro activity of RU 64004, a new ketolide antibiotic, against Gram-positive bacteria. Antimicrob. Agents Chemother. (1997) 41:1196–1202.
   PubMed Web of Science ®Google Scholar
• AGOURIDAS C, BONNEFOY A, CHANTOT JF: In vitro anti-bacterial activity of RU 004, a novel ketolide highly ac-tive against respiratory pathogens. 35th ICAAC. San Francisco, CA, USA (1995):140. Abstract F–158.
   Google Scholar
• EDNIE LM, SPANGLER SK, JACOBS MR, APPELBAUM PC:Susceptibilities of 228 penicillin and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide compared with susceptibilities to 16 other agents. Antimicrob. Agents Chemother. (1997) 41:1033–1036.
   PubMed Web of Science ®Google Scholar
• FREMEAUX A, SISSIA G, CHANTOT J-F, GESLIN P: Antibac-terial activity of the ketolide RU 004 against multi-resistant pneumococci. 35th ICAAC. San Francisco, CA, USA (1995):141. Abstract F–160.
   Google Scholar
• RAJAGOPALAN-LEVASSEUR P, VALLEE E, AGOURIDAS C, CHANTOT J-F, POCIDALO J-J: RU 004: activity against erythromycin-resistant pneumococci and Haemophi-lus influenzae in murine pneumonia model. 35th ICAAC. San Francisco, CA, USA (1995):143. Abstract F–173.
   Google Scholar
• EDNIE LM, SPANGLER SK, JOCOBS MR, APPELBAUM PC:Antianaerobic activity of the ketolide RU 64004 com-pared to activities of four macrolides, five p-lactams, clindamycin, and metronidazole. Antimicrob. Agents Chemother. (1997) 41:1037–1041.
   PubMed Web of Science ®Google Scholar
• DABERNAT H, SEGUY M, DELMAS C: In vitro activity ofRU 004 against Haemophilus influenzae and Morax-ella catarrhalis. 35th ICAAC. San Francisco, CA, USA (1995):141. Abstract F–161.
   Google Scholar
• FABRE R, CAVALLO JD, CHAPALAN JC, MEYRAN M: Com-parative in vitro activity of RU 004 against Neisseria gonorrhoeae and Neisseria meningitidis. 35th ICAAC. San Francisco, CA, USA (1995):141. Abstract F–164.
   Google Scholar
• HAIDER F, EB I, ORFILA J: Ketolides and Chlamydia: in vi-tro evaluation of RU 004. 35th ICAAC. San Francisco, CA, USA (1995):142. Abstract F–165.
   Google Scholar
• BORNSTEIN N BEHR H, BRUN Y, FLEURETTE J: In vitro ac-tivity of RU 004 on Legionella species. 35th ICAAC. San Francisco, CA, USA (1995):142. Abstract F–166.
   Google Scholar
• ASAKA T, KASHIMURA M, MISAWA Y et al.: A new mac-rolide antibiotic, TE-810, synthesis and biological prop-erties. 35th ICAAC. San Francisco, CA, USA (1995) :144. Abstract F177.
   Google Scholar
• ASAKA T, KASHIMURA M, MISAWA Y et al.: A new mac-rolide antibiotic, TE-802, synthesis and biological prop-erties. 35th ICAAC. San Francisco, CA, USA (1995):143. Abstract F176.
   Google Scholar
• PHAN LYT, OR YT, SPINA KP et al.: Tricyclic ketolides: monosubstitution on the imine ring. Synthesis and in vitro antibacterial activity. 37th ICAAC, Toronto, Canada (1997):190. Abstract F–263.
   Google Scholar
• PHAN LYT, OR, YT, CHEN Y et al: Tetracyclic ketolides: a new antibacterial macrolides. Synthesis and in vitro an-tibacterial activity. 37th ICAAC. Toronto, Canada (1997): 190. Abstract F–264.
   Google Scholar
• ASAKA T, KASHIMURA M, TANIKAWA T et al.: New mac-rolide antibiotics, acyclides (3-0-acy1-5-0-desosaminyl erythronolides); synthesis and biological properties. 37th ICAAC. Toronto, Canada (1997):190. Abstract F–262.
   Google Scholar
• GRIESGRABER G, ELLIOT RL, KRAMER MJ et al.: Synthesisand in vitro activity of novel 2,3-anhydro-11-hydrazo-6-0-mehty1-11,12-carbamate erythromycin deriva-tives. 37th ICAAC. Toronto, Canada (1997):191. Abstract F–266.
   Google Scholar
• ELLIOT RL, PIREH D, GRIESGRABER G et al: Synthesis andin vitro activity of novel 2,3 anhydro-6-0-methyl-11,12 -carbamate erythromycin analogue. 37th ICAAC. To-ronto (Canada) (1997) 191. Abstract F–265.
   Google Scholar
• KIRST HA: Macrolides antibiotics in food-animal health. Exp. Opin. Invest. Drugs (1997) 6:103–117.
   PubMedGoogle Scholar
• LIU L, ROETS E, BUSSON R et al: Two novel spiramycins obtained from commercial samples: isolation and elu-cidation of structure. J. Antibiot. (1996) 49:398–401.
   PubMed Web of Science ®Google Scholar
• AJITO K, KUHIHARA KI, SHIBAHARA S et al.: Cladinoseanalogues of sixteen membered macrolide antibiotics. II. Preparation of pharmacokinetically improved ana-logues via biotransformation. J. Antibiot. (1997) 50:92–95.
   Google Scholar
• AJITO K, KURIHARA KI, SHIBAHARA S et al.: Cladinoseanalogues of sixteen membered macrolides antibiotics. IV. Improved therapeutic effects of 4-0-acyl-L-cladinose analogues of sixteen membered macrolides antibiotics. J. Antibiot. (1997) 50:150–161
   Google Scholar
• AJITO K, SHIMIZU A, SHIBAHARA S et al.: Cladinose ana-logues of sixteen-membered ring macrolide antibiot-ics. V. Preparation of unsubstituted analogues: effect of methylation of a 3146-hydroxyl group on the bioactiv-ity. J. Antibiot. (1997) 41:366–369
   Google Scholar
• TATSUTA K, TANAKU A, KINOSHITA M, UMEZAWA S: Syn-thesis of cladinose analogues of carbomycin B. Chem. Lett. (1977):769–772.
   Web of Science ®Google Scholar
• SHOMURA T, SOMEYA S, UMEMURA K, NISHIO M, MU-RATA S: Metabolism of 9,3"-diacetylmidecamycin. I. The metabolic fate of 9,3"-diacetylmidecamycin. Yaku-gakuzasshi (Japanese) (1982) 102:781–795.
   PubMed Web of Science ®Google Scholar
• KURIHARA K, AJITO K, SHIBAHARA S et al.: Cladinoseanalogues of sixteen-membered macrolide antibiotics. I. Synthesis of 4-0-alkyl-L-cladinose analogues via gly-cosylation. j Antibiot. (1996) 49:582–592.
   Google Scholar
• KURIHARA KI, KIKUCHI N, AZITO K: Cladinose ana-logues of sixteen membered macrolides antibiotics. III. Efficient synthesis of 4–0-alkyl-L-cladinose analogues: improved antibacterial activities compatible with phar-macokinetics. j Antibiot. (1997) 50:32–44.
   Google Scholar
• NARANDJA A, KELNERIC Z, LOPOTAR N: Structure-activity relationship among new dihydro derivatives of 4-dimycarosyltylosin. 3rd International Conference on Macrolides, Azalides and Streptogramins. Lisbon, Portugal (1996).
   Google Scholar
• KELNERIC Z, HAJSIG D, NARANDJA A et al.: Comparativein vitro activities of tylosin and new tetrahydro deriva-tives of tylosin against bacterial skin pathogens of ani-mal origins. 3rd International Conference on Macrolides, Azalides and Streptogramins. Lisbon, Portugal (1996).
   Google Scholar
• MACFARLAND JW, BERGER CM, FROHSHAUER SA et al.:Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo po-tency against Pasteurella multocida. J. Med. Chem. (1997) 40:1340–1346.
   PubMed Web of Science ®Google Scholar
• MACFARLAND JW, BERGER CM, LIPINSKI A et al.: New macrolide antibacterial agents : the discovery of potent activity against Pasteurella multocida among repromi-cin derivatives. 20th IUPAC Symposium on the Chemistry of Natural Product. Chicago, USA (1996).
   Google Scholar
• GRANDJEAN C, LUCKACS G: Synthesis of 4'-0-demycaro-sy1-3-0-(a-L-rhamnopyranosy0 tylosin. Bull. Soc. Clin. Fr. (1995) 132:1145–1148.
   Google Scholar
• KIM SD, RY00 IJ, KIM CJ et al.: GERI 155, a new macrolide antibiotic related to chalcomycin. j Antibiol (1996) 49:955–957.
   Google Scholar
• GO YM, LEE YY, KIM BT: A new 16-membered chalcomy-cin type macrolide antibiotic 250-144C. J. Antibiol (1997) 50:85–88.
   PubMed Web of Science ®Google Scholar